Literature DB >> 16310447

The Editor's roundtable: cyclooxygenase-2 inhibitors and cardiovascular risk.

Robert S Bresalier1, Vincent E Friedewald, Robert E Rakel, William C Roberts, Gary W Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16310447     DOI： 10.1016/j.amjcard.2005.09.069

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  2 in total

Review 1.  Therapeutic targets in prostaglandin E2 signaling for neurologic disease.

Authors:  P J Cimino; C Dirk Keene; Richard M Breyer; Kathleen S Montine; Thomas J Montine
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

2.  Elevated ratio of urinary metabolites of thromboxane and prostacyclin is associated with adverse cardiovascular events in ADAPT.

Authors:  Thomas J Montine; Joshua A Sonnen; Ginger Milne; Laura D Baker; John C S Breitner
Journal:  PLoS One       Date:  2010-02-19       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.